ObjectiveThe purpose of the study was to identify determinants of late antennal care at first visit in health facilities of eastern zone of Tigray, Northern Ethiopia 2018.ResultWomen with unplanned pregnancy (AOR = 4.03, 95%, CI 1.56–5.67), Participants whose previous first antenatal care was after 16 weeks (AOR = 3.9, 95% CI 1.98–7.68), Participants did not accompanied by their partner for antenatal visit (AOR = 1.29, 95%, CI 1.05–4.67), women recognized their current pregnancy at 3 months or late (AOR = 4.7, 95%, CI 2.49–9.04) and participants provided adequate time for their previous antenatal care by health professionals (AOR = 0.461, 95% CI 0.342–0.875) were found the determinant factors of late antenatal care at first Visit. Hence family planning utilization, times of first visit antenatal, information flow and supporting by partners have a great role in improving antenatal care at first visit. There for responsible bodies should give focuses on utilization of family planning, increasing awareness of pregnancy symptoms and health provisional provide adequate time during visits.
Background Thyrotoxicosis is the state of thyroid hormone excess. But, in sub-Saharan Africa (SSA), specifically Northern Ethiopia, scientific evidence about thyrotoxicosis and its cardiac complications like dilated cardiomyopathy is limited. Therefore, this study aimed to explore the thyrotoxicosis presentation and management and identify factors associated with dilated cardiomyopathy in a tertiary hospital in Northern Ethiopia. Methods An institution-based cross-sectional study was conducted in Ayder Comprehensive Specialized Hospital from 2017 to 2018. Data from 200 thyrotoxicosis cases were collected using a structured questionnaire. After describing variables, logistic regression was conducted to identify independent predictors of dilated cardiomyopathy. Statistical significance was declared at p < 0.05. Results Mean age at presentation of thyrotoxicosis was 45 years and females accounted for 89 % of the cases. The most frequent etiology was multinodular toxic goiter (51.5 %). As well, the most common symptoms and signs were palpitation and goiter respectively. Thyroid storm occurred in 6 % of the cases. Out of 89 patients subjected to echocardiography, 35 (39.3 %) of them had dilated cardiomyopathy. And, the odds of dilated cardiomyopathy were higher in patients who had atrial fibrillation (AOR = 15.95, 95 % CI:5.89–38.16, p = 0.001) and tachycardia (AOR = 2.73, 95 % CI:1.04–7.15, p = 0.040). All patients took propylthiouracil and 13.0 % of them experienced its side effects. Concerning β-blockers, propranolol was the most commonly (78.5 % of the cases) used drug followed by atenolol (15.0 %). Six patients underwent surgery. Conclusions In developing countries like Ethiopia, patients with thyrotoxicosis have no access to methimazole which is the first-line anti-thyroid drug. Besides, they greatly suffer from dilated cardiomyopathy (due to late presentation) and side effects of propylthiouracil. Therefore, we recommend that patients should get adequate health information about thyrotoxicosis and anti-thyroid drugs including their side effects. Additionally, hospitals and other concerned bodies should also avail of TSH tests and methimazole at an affordable cost. Furthermore, community awareness about iodized salt and iodine-rich foods should be enhanced.
Objective: The purpose of the study was to identify determinants of late antennal care at first visit in health facilities of eastern zone of Tigray, Northern Ethiopia 2018. Result: Women with unplanned pregnancy (AOR= 4.03, 95%, CI: 1.56-5.67), Participants whose previous first antenatal care was after 16 weeks (AOR= 3.9, 95% CI: 1.98-7.68), Participants did not accompanied by their partner for antenatal visit (AOR= 1.29,95%, CI: 1.05-4.67), women recognized their current pregnancy at three months or late ( AOR= 4.7,95%,CI: 2.49-9.04) and participants provided adequate time for their previous antenatal care by health professionals ( AOR = 0.461, 95% CI 0.342- 0.875) were found the determinant factors of late antenatal care at first Visit. Hence family planning utilization, times of first visit antenatal, information flow and supporting by partners have a great role in improving antenatal care at first visit. There for responsible bodies should give focuses on utilization of family planning, increasing awareness of pregnancy symptoms and health provisional provide adequate time during visits.
Objective: The purpose of the study was to identify determinants of late antennal care at first visit in health facilities of eastern zone of Tigray, Northern Ethiopia 2018. Result : Women with unplanned pregnancy (AOR= 4.03, 95%, CI: 1.56-5.67),Participants whose previous first antenatal care was after 16 weeks (AOR= 3.9, 95% CI: 1.98-7.68), Participants did not accompanied by their partner for antenatal visit (AOR= 1.29,95%, CI: 1.05-4.67), women recognized their current pregnancy at three months or late ( AOR= 4.7,95%,CI: 2.49-9.04) and participants provided adequate time for their previous antenatal care by health professionals ( AOR = 0.461, 95% CI 0.342- 0.875) were found the determinant factors of late antenatal care at first Visit. Hence family planning utilization, times of first visit antenatal, information flow and supporting by partners have a great role in improving antenatal care at first visit. There for responsible bodies should give focuses on utilization of family planning, increasing awareness of pregnancy symptoms and health provisional provide adequate time during visits.
Background: Thyrotoxicosis is the state of thyroid hormone excess with a spectrum of disease ranging from mild to life-threatening complications like thyrotoxic cardiomyopathy and thyroid storm. This study aims to explore the pattern, clinical manifestation, complication, management, and drug adherence of patients with thyrotoxicosis in a tertiary hospital of Northern Ethiopia. Methods: An institution-based cross-sectional study was conducted in Ayder Comprehensive Specialized Hospital from 2017 to 2018. Data from a 200 thyrotoxicosis cases was collected using a structured questionnaire that includes Morisky Medication Adherence Scale questions. After describing variables, a logistic regression was conducted to identify independent predictors of dilated cardiomyopathy and drug adherence. Statistical significance was declared at p<0.05. Results: Mean age at presentation of thyrotoxicosis was 45 years and females accounted for 89% of the cases. As well, the most common symptom and sign were palpitation and goiter respectively. Thyroid storm occurred in 6% of the cases. Out of 89 patients subjected for echocardiography, 35 (39.3%) of them had dilated cardiomyopathy. And, the odds of dilated cardiomyopathy was higher in patients who had atrial fibrillation (AOR=15.95, 95% CI:5.89-38.16, p=0.001) and tachycardia (AOR=2.73, 95% CI:1.04-7.15, p=0.040). All patients took propylthiouracil and 13.0% of them experienced its side effects. Concerning β-blockers, propranolol was the most commonly (78.5% of the cases) used drug followed by atenolol (15.0%). Six patients underwent surgery. Lastly, drug non-adherence rate was 26% and it was significantly associated with illiteracy, side effect, lack of information and infrequent TSH follow-up. Conclusions: In developing countries like Ethiopia, patients with thyrotoxicosis have no access to methimazole which is the first-line anti-thyroid drug. In addition, they greatly suffer from dilated cardiomyopathy due to late presentation and side effects of propylthiouracil. Therefore, we recommend that patients should get adequate health information about thyrotoxicosis and anti-thyroid drugs including their side effects. Additionally, hospitals and other concerned bodies should also avail TSH test and methimazole at an affordable cost.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.